PFN2 and non-small cell lung carcinoma: In NSCLC, miR-30a-5p suppresses epithelial-mesenchymal transition of cell lines in highly invasive NSCLC via targeting profilin-2 [34], and can strengthen the sensitivity of paclitaxel to NSCLC by targeting BCL-2 expression [35].